A great discussion at #ESCCongress2026 during our session on inequalities & disparities in cardiovascular health.
Excellent presentations from @RBugiardini@maryamkavousi Antonia Sambola & @CVR_TomaszGuzik on diet, sex & gender, ethnicity & race, & hypertension
At #ESCCongress 2026, @escardio WG on Coronary Pathophysiology & Microcirculation invites yuo to join:
🫀 Leave nothing behind: fact or fiction?
📅 29 Aug | 08:15–09:45
📍 Bratislava, ICM
👉https://t.co/v6H3KOx9hV
@EdinaCenko@maria_bergami#WGCPM_ESC#ESC
At #ESCCongress 2026 @escardio Working Group on Coronary Pathophysiology & Microcirculation invites you to explore
❤️ Non-conventional risk factors for CVD
📅 28 Aug | 08:15–09:45
📍 Chisinau, Hall B1
👉https://t.co/TRroZu6I9a
@cpgale3@EdinaCenko@maria_bergami#WGCPM_ESC
💔 Why do heart attack patients with NO traditional risk factors face higher short-term mortality?
This "paradox" likely reflects index-event & dilution bias
Congrats to all co-authors! 👏
👇
https://t.co/9cTXhhGvs0
@EdinaCenko@maria_bergami@RBugiardini@ATHjournal
❤️ What's New in Prediction and Prevention of Cardiovascular Complications in Diabetes?
Still a few seats left!
👉Free and open to all. Register now: https://t.co/QuHoSmPuLE
@EdinaCenko@WGCPMChair@ESCWGAVBChair@escardio#WGCPM_ESC
🫀Despite successful primary PCI MVO occurs in up to 60% of #STEMI pts & remains a key driver of HF & mortality
Read the new #ESC Clinical Consensus Statement on the Pathophysiology Prevention & Management of Coronary MVO
👉https://t.co/1ej9m0H6du
@EdinaCenko@ehj_ed@escardio
Coronary microvascular obstruction: the "no-reflow" problem that haunts STEMI care. New ESC clinical consensus on pathophysiology, prevention & management: a must-read. Read more in #EHJ.
https://t.co/WWlcFSfVyj
#cardiotwitter@ESC_Journals@escardio
Does physician sex influence CV outcomes?
This article reviews evidence suggesting outcome differences may exist across settings, highlighting possible links to communication, guideline use, and care delivery, while noting the complexity of causality.
https://t.co/c7LGXK9GGN
Rethink beta-blockers for uncomplicated hypertension?
Our @HyperAHA commentary: despite guideline upgrades evidence for routine use in uncomplicated cases is limited
👉 https://t.co/VJmEEBcKqM
Persistent angina after revascularisation? 🫀
Join the @escardio#WGCPM_ESC & WGCARE_ESC for a free webinar on Residual vs. Refractory Angina
Explore strategies for your toughest cases
📅 29 May | 16:00 CEST
🔗 https://t.co/33mFdPWtMe
@EdinaCenko@ItaloPorto2@RiSanz2020
Women’s heart health remains at risk as gaps in sex-specific research, male-focused diagnostics, and low trial enrollment contribute to underdiagnosis and undertreatment.
Sex-specific studies are vital to advance care and equity in cardiology.
Read more: https://t.co/JiD7eXyoH8
A new article in the European Heart Journal highlights an important dimension of cardiovascular care: “Cardiovascular disease outcomes: does physician’s sex matter?” Click on the link to learn more about this interesting topic!
https://t.co/rhlfTTImdw